METRIX AIR
Report
- Report Number
- 1000113657-2016-01472
- Event Type
- Malfunction
- Date Received
- September 8, 2016
- Date of Event
- August 16, 2016
- Report Date
- September 8, 2016
- Manufacturer
- TRIVIDIA HEALTH, INC.
- Product Code
- NBW
- PMA / PMN Number
- K150052
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- LA
- Reporter Occupation
- OTHER
Narratives
(B)(4). INVESTIGATION COMPLETED AND PRODUCT EVALUATED WITH NO DEFECT FOUND ON RETURNED METER. MOST LIKELY UNDERLYING ROOT CAUSE OF MALFUNCTION: USER HAD AN INACCURATE REFERENCE.
CONSUMER REPORTED COMPLAINT FOR HIGH BLOOD GLUCOSE TEST RESULTS. THE CUSTOMER IS CONCERNED WITH TESTS RESULTS FROM RESULTS OBTAINED OF 133, 84 AND 125 MG/DL. THE CUSTOMER'S EXPECTED FASTING BLOOD GLUCOSE TEST RESULT RANGE IS 50 - 125 MG/DL. THE CUSTOMER FEELS WELL AND DID NOT REPORT ANY SYMPTOMS. MEDICAL ATTENTION IS NOT REPORTED AS A RESULT OF THE ACTUAL BLOOD GLUCOSE RESULTS. DURING THE CALL ON (B)(6) 2016, A BACK TO BACK BLOOD TEST WAS PERFORMED BY THE CUSTOMER NON-FASTING AND PRODUCED TEST RESULTS OF 281 MG/DL AND 261 MG/DL. THE PRODUCT IS STORED ACCORDING TO SPECIFICATION IN THE DEN. THE TEST STRIP LOT MANUFACTURER'S EXPIRATION DATE IS 09/23/2017 AND OPEN VIAL DATE IS (B)(6) 2016. THE CUSTOMER STATED THAT HE HAS NOT HAS ANY CHANGES TO HIS LIFESTYLE. THE CUSTOMER STATED HE ISS CURRENTLY ON METFORMIN, TWO 500 MG TABLETS AT BEDTIME. THE METER MEMORY WAS REVIEWED FOR PREVIOUS TEST RESULT HISTORY: (B)(6). MEMORY CONCERNS: CUSTOMER IS CONCERNED WITH RESULTS: 148 MG/DL, 133 MG/DL THE CUSTOMER VERIFIED THAT HE HAS NOT HAS ANY CHANGES TO HIS LIFESTYLE. I RAN A CONTROL TEST WITH THE CUSTOMER WITH A RESULT OF 43 MG/DL, WHICH WAS WITHIN RANGE. CONTROL LOT # 6BC1A14; OPEN VIAL DATING: (B)(6) 2016. LEVEL: 1, RANGE: 23-53 MG/DL, RESULT: 43 MG/DL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 587468 | METRIX AIR | BLOOD GLUCOSE SYSTEM | NBW | TRIVIDIA HEALTH, INC. | METRIX AIR | MT1688 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 0 YR | SECOND THERAPY |